Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 29,594 | 26,034 | 23,208 | 9,838 | -16,817 |
| Depreciation Amortization | 7,074 | 4,166 | 2,096 | 1,274 | 5,996 |
| Accounts receivable | 8,578 | 6,818 | 12,946 | -4,233 | -2,581 |
| Other Working Capital | 8,718 | -1,858 | -205 | -7,659 | -18,671 |
| Other Operating Activity | -4,413 | -3,411 | -10,755 | 7,679 | 11,951 |
| Operating Cash Flow | $49,551 | $31,749 | $27,290 | $6,899 | $-20,122 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,103 | -783 | -111 | -92 | -111 |
| Net Acquisitions | -12,996 | -7,296 | -7,296 | N/A | N/A |
| Purchase Of Investment | -275,198 | -220,738 | -125,987 | -99,659 | -252,092 |
| Sale Of Investment | 196,728 | 146,528 | 122,875 | 93,200 | 288,462 |
| Purchase Sale Intangibles | -5,174 | -2,364 | -818 | -100 | -3,248 |
| Other Investing Activity | -4,588 | -2,364 | -818 | -100 | -3,624 |
| Investing Cash Flow | $-97,157 | $-84,653 | $-11,337 | $-6,651 | $32,635 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8,961 | N/A | 0 | 0 | -12,273 |
| Common Stock Issued | 71,247 | 71,158 | 354 | 183 | 995 |
| Other Financing Activity | -28 | -28 | 0 | 0 | -25,751 |
| Financing Cash Flow | $62,258 | $71,130 | $354 | $183 | $-37,029 |
| Exchange Rate Effect | -7 | 24 | 0 | N/A | N/A |
| Beginning Cash Position | 27,687 | 27,687 | 27,687 | 27,687 | 52,203 |
| End Cash Position | 42,332 | 45,937 | 43,994 | 28,118 | 27,687 |
| Net Cash Flow | $14,645 | $18,250 | $16,307 | $431 | $-24,516 |
| Free Cash Flow | |||||
| Operating Cash Flow | 49,551 | 31,749 | 27,290 | 6,899 | -20,122 |
| Capital Expenditure | -1,103 | -783 | -111 | -92 | -111 |
| Free Cash Flow | 48,448 | 30,966 | 27,179 | 6,807 | -20,233 |